A team of Harvard scientists found that some human melanoma cells that produce a chemotherapy-resistant protein caused tumors to develop in mice. The finding suggests that these cells can be characterized as cancer stem cells. Researchers also have developed an antibody directed against the protein and demonstrated its ability to delay the progression of tumors in mice.

Related Summaries